ArticlePotential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional NetworkAuthor:Steve Flynn, PharmD, BCPS Publish date: May 8, 2026Chronic myeloid leukemia (CML) is a hematologic malignancy resulting from an acquired mutation. Read More
